SAB Biotherapeutics Inc (SABS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -5.59 | -43.029 | -28.772 | -62.581 |
Return on Equity (%) | -112.5 | -88.913 | -53.847 | -95.508 |
Return on Invested Capital (%) | 8.219 | -87.422 | -93.829 | -86.966 |
Operating Margin (%) | N/A | -27.681 | -77.033 | -1870.433 |
Net Profit Margin (%) | N/A | -28.164 | -78.401 | -1884.502 |
Book Value Per Share | 0.006 | 0.886 | 0.722 | 1.095 |
Earnings Per Share | -0.003 | -0.394 | -0.436 | -0.806 |
Cash Per Share | 0.03 | 0.764 | 0.35 | 1.081 |
Working Capital Per Share | -0.076 | 0.546 | 0.165 | 0.919 |
Operating Profit Per Share | N/A | 1.4 | 0.556 | 0.043 |
EBIT Per Share | -0.003 | -0.394 | -0.435 | -0.806 |
EBITDA Per Share | -0.003 | -0.394 | -0.435 | -0.806 |
Free Cash Flow Per Share | -0.003 | -0.177 | -0.459 | -0.873 |
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Actions en circulation | 2,88M | 43,49M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1249.914 | N/A | N/A | N/A | -523.704 | N/A | N/A |
Net Profit Margin (%) | N/A | -1265.749 | N/A | N/A | N/A | -531.852 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 35,99M |
Ratio cours/bénéfice | -1,01 |
Ratio prix/ventes | 19,08 |
Ratio prix/liquidités | 0,76 |
Ratio prix/valeur comptable | 0,75 |
Rendement de dividende | - |
Actions en circulation | 9,23M |
Volume moyen (1 semaine) | 87,55k |
Volume moyen (1 mois) | 90,46k |
Variation sur 52 semaines | -40,66% |
Plus haut sur 52 semaines | 7,70 |
Plus bas sur 52 semaines | 2,16 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales